SlideShare is now on Android. 15 million presentations at your fingertips.  Get the app

×
  • Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 

FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug Information

by Smashing Silos, Building Connections at Path of the Blue Eye Project on Jan 04, 2012

  • 1,428 views

Draft FDA guidance focusing on how drug firms should respond to unsolicited requests for information about drugs and medical devices.

Draft FDA guidance focusing on how drug firms should respond to unsolicited requests for information about drugs and medical devices.

Statistics

Views

Total Views
1,428
Views on SlideShare
1,428
Embed Views
0

Actions

Likes
1
Downloads
17
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via SlideShare as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
Post Comment
Edit your comment

FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug Information FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug Information Document Transcript